Published in Pediatr Blood Cancer on March 25, 2011
SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma. Clin Cancer Res (2015) 1.52
Targeting the DNA repair pathway in Ewing sarcoma. Cell Rep (2014) 1.09
ZEB2 Represses the Epithelial Phenotype and Facilitates Metastasis in Ewing Sarcoma. Genes Cancer (2013) 0.91
Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma. Mol Ther (2015) 0.91
Ewing's sarcoma: overcoming the therapeutic plateau. Discov Med (2012) 0.91
Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma. Oncotarget (2015) 0.85
Differentially expressed miRNAs in Ewing sarcoma compared to mesenchymal stem cells: low miR-31 expression with effects on proliferation and invasion. PLoS One (2014) 0.84
The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities. Dev Biol (2015) 0.82
Bone sarcomas: from biology to targeted therapies. Sarcoma (2012) 0.82
Sarcomas gone bad: what to do about recurrent Ewing sarcoma. Pediatr Blood Cancer (2011) 0.82
Development and characterization of a human orthotopic neuroblastoma xenograft. Dev Biol (2015) 0.80
The clone wars - revenge of the metastatic rogue state: the sarcoma paradigm. Front Oncol (2012) 0.79
Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma. Curr Opin Oncol (2014) 0.79
Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells. Cancer Biol Ther (2013) 0.79
Three-year Follow up of GMCSF/bi-shRNA(furin) DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma. Mol Ther (2016) 0.77
Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT. Br J Cancer (2013) 0.77
Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma. PLoS One (2016) 0.76
High tumor volume and local recurrence following surgery in osteosarcoma: A retrospective study. Indian J Orthop (2014) 0.76
Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma. Mol Ther (2016) 0.75
UK guidelines for the management of bone sarcomas. Clin Sarcoma Res (2016) 0.75
Prospective immunotherapies in childhood sarcomas: PD1/PDL1 blockade in combination with tumor vaccines. Pediatr Res (2015) 0.75
Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials. Oncotarget (2016) 0.75
[Primary malignant bone tumors: prognostic factors - remission]. Orthopade (2013) 0.75
miR-124 represses the mesenchymal features and suppresses metastasis in Ewing sarcoma. Oncotarget (2016) 0.75
Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group. Int J Radiat Oncol Biol Phys (2017) 0.75
Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002. Mol Ther Oncolytics (2017) 0.75
EWS-FLI1 positively regulates autophagy by increasing ATG4B expression in Ewing sarcoma cells. Int J Mol Med (2017) 0.75
Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol (2002) 10.03
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol (2003) 3.93
Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol (2005) 3.29
Ewing's sarcoma family of tumors: current management. Oncologist (2006) 2.97
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell (2008) 2.78
Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol (2008) 2.63
Forensic Age Estimation. Dtsch Arztebl Int (2016) 2.55
Transforaminal lumbar interbody fusion: a safe technique with satisfactory three to five year results. Eur Spine J (2005) 2.32
Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res (2006) 2.13
Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol (2008) 1.95
Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol (2010) 1.88
The diagnostic imaging of bone metastases. Dtsch Arztebl Int (2014) 1.83
Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol (2003) 1.78
Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. Am J Pathol (2010) 1.76
Forensic age estimation in living individuals using 3.0 T MRI of the distal femur. Int J Legal Med (2014) 1.72
Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys (2003) 1.70
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial. Pediatr Blood Cancer (2006) 1.69
Silver-coated megaendoprostheses in a rabbit model--an analysis of the infection rate and toxicological side effects. Biomaterials (2004) 1.69
Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood (2007) 1.67
Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J Clin Oncol (2010) 1.65
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer (2004) 1.65
Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma. J Clin Oncol (2011) 1.64
Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma. J Cancer Res Clin Oncol (2005) 1.59
Forensic age estimation in living subjects based on the ossification status of the medial clavicular epiphysis as revealed by thin-slice multidetector computed tomography. Int J Legal Med (2009) 1.58
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells. Cancer Res (2005) 1.55
Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med (2002) 1.53
Enhanced possibilities to make statements on the ossification status of the medial clavicular epiphysis using an amplified staging scheme in evaluating thin-slice CT scans. Int J Legal Med (2010) 1.45
Nutritional status of children and young adults with Ewing sarcoma or osteosarcoma at diagnosis and during multimodality therapy. Pediatr Blood Cancer (2011) 1.44
Idiopathic thrombocytopenic purpura (ITP): is there a genetic predisposition? Pediatr Blood Cancer (2006) 1.41
Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors. J Immunother (2005) 1.41
Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts. Eur Spine J (2013) 1.41
Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer (2006) 1.40
Bone tumors in adolescents and young adults. Curr Treat Options Oncol (2008) 1.33
Giant cell tumors of the axial skeleton. Sarcoma (2012) 1.29
Treatment and outcome of giant cell tumors of the pelvis. Acta Orthop (2009) 1.28
Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma. Clin Cancer Res (2010) 1.25
Grade I chondrosarcoma of bone: the Münster experience. J Cancer Res Clin Oncol (2008) 1.25
Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group. Cancer (2002) 1.25
Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study group. Oral Oncol (2007) 1.24
Treatment options for recurrent giant cell tumors of bone. J Cancer Res Clin Oncol (2008) 1.24
The value of sub-stages and thin slices for the assessment of the medial clavicular epiphysis: a prospective multi-center CT study. Forensic Sci Med Pathol (2013) 1.23
Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer (2010) 1.23
Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis. J Clin Oncol (2013) 1.21
Projection radiography of the clavicle: still recommendable for forensic age diagnostics in living individuals? Int J Legal Med (2014) 1.18
Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur J Cancer (2008) 1.18
Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia. J Allergy Clin Immunol (2004) 1.17
The role of radiotherapy in oseosarcoma. Cancer Treat Res (2009) 1.14
Immature CD34+CD19- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal. Blood (2002) 1.12
The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer (2010) 1.12
High-resolution magnetic resonance imaging of the temporomandibular joint: image quality at 1.5 and 3.0 Tesla in volunteers. Invest Radiol (2007) 1.11
Disc height reduction in adjacent segments and clinical outcome 10 years after lumbar 360 degrees fusion. Eur Spine J (2007) 1.10
Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors. Pediatr Blood Cancer (2006) 1.09
Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition. J Pathol (2009) 1.09
Ewing sarcoma: clinical state-of-the-art. Pediatr Hematol Oncol (2012) 1.09
Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party. Strahlenther Onkol (2009) 1.08
Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas. Cancer Res (2010) 1.08
Periosteal osteosarcoma--a European review of outcome. Eur J Cancer (2005) 1.07
Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2. Cell Cycle (2009) 1.06
Distal femur and proximal tibia replacement with megaprosthesis in revision knee arthroplasty: a limb-saving procedure. Knee Surg Sports Traumatol Arthrosc (2012) 1.05
Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahlenther Onkol (2005) 1.05
Pain in pediatric oncology--children's and parents' perspectives. Eur J Pain (2005) 1.04
Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors. J Nucl Med (2007) 1.04
Bone structure of the distal radius and the calcaneus vs BMD of the spine and proximal femur in the prediction of osteoporotic spine fractures. Eur Radiol (2001) 1.04
Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity. Br J Haematol (2004) 1.04
The iliac crest in forensic age diagnostics: evaluation of the apophyseal ossification in conventional radiography. Int J Legal Med (2012) 1.04
Whole lung irradiation in patients with exclusively pulmonary metastases of Ewing tumors. Toxicity analysis and treatment results of the EICESS-92 trial. Strahlenther Onkol (2008) 1.04
Hip transposition as a limb salvage procedure following the resection of periacetabular tumors. J Surg Oncol (2010) 1.03
Influence of the examiner's qualification and sources of error during stage determination of the medial clavicular epiphysis by means of computed tomography. Int J Legal Med (2013) 1.02
Odontogenic myxoma: diagnostic and therapeutic challenges in paediatric and adult patients--a case series and review of the literature. J Craniomaxillofac Surg (2011) 1.01
The role of interferons in the treatment of osteosarcoma. Pediatr Blood Cancer (2010) 1.01
Magnetic resonance imaging of the iliac crest: age estimation in under-20 soccer players. Forensic Sci Med Pathol (2014) 0.99
Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor. BMC Cancer (2010) 0.99
Primary stability in cementless femoral stems: custom-made versus conventional femoral prosthesis. Clin Biomech (Bristol, Avon) (2002) 0.99
Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol (2006) 0.98
Cameriere's approach modified for pelvic radiographs: a novel method to assess apophyseal iliac crest ossification for the purpose of forensic age diagnostics. Int J Legal Med (2013) 0.98
High-resolution MRI vs multislice spiral CT: which technique depicts the trabecular bone structure best? Eur Radiol (2002) 0.97
Radiotherapy in Ewing tumors of the vertebrae: treatment results and local relapse analysis of the CESS 81/86 and EICESS 92 trials. Int J Radiat Oncol Biol Phys (2005) 0.96
A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease. Int J Cancer (2009) 0.96